or Try an Advanced Search...

    Technical Analysis for ANVS - Annovis Bio, Inc.

    Grade Last Price % Change Price Change
    F 5.37 -0.37% -0.02
    ANVS closed up 4.05 percent on Monday, May 6, 2024, on 76 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 9
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ANVS trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction -0.37%
    NR7 Range Contraction -0.37%
    Narrow Range Bar Range Contraction -0.37%
    Wide Bands Range Expansion -0.37%
    Oversold Stochastic Weakness -0.37%
    New 52 Week Closing Low Bearish 3.67%
    Calm After Storm Range Contraction 3.67%
    Narrow Range Bar Range Contraction 3.67%
    New 52 Week Low Weakness 3.67%
    Wide Bands Range Expansion 3.67%
    Older End-of-Day Signals for ANVS ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 1 hour ago
    Up 3% about 1 hour ago
    60 Minute Opening Range Breakdown about 1 hour ago
    Down 3% about 1 hour ago
    Down 2 % about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ANVS Chart by TradingView
    Basic chart:

    Profile

    Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Alzheimer's Disease Parkinson's Disease Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Early Stage Alzheimer's Disease Gladstone Institutes

    Is ANVS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 6 Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
    May 3 Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
    May 2 Annovis Bio: Alzheimer's Disease Topline Data Disappoints The Market
    May 2 Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
    May 2 Impact Of Buntanetap Trial Results On Annovis Bio Stock And Future Prospects
    May 2 Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
    May 2 Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question
    Apr 30 Annovis Bio: Searching For Efficacy In Alzheimer's Disease
    Apr 29 Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Apr 29 Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study
    See more ANVS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.49
    52 Week Low 4.86
    Average Volume 523,208
    200-Day Moving Average 10.46
    50-Day Moving Average 10.07
    20-Day Moving Average 9.99
    10-Day Moving Average 9.12
    Average True Range 1.86
    RSI (14) 37.50
    ADX 22.84
    +DI 22.42
    -DI 30.30
    Chandelier Exit (Long, 3 ATRs) 14.41
    Chandelier Exit (Short, 3 ATRs) 10.45
    Upper Bollinger Bands 16.51
    Lower Bollinger Band 3.47
    Percent B (%b) 0.15
    BandWidth 130.56
    MACD Line -1.28
    MACD Signal Line -0.49
    MACD Histogram -0.7959
    Fundamentals Value
    Market Cap 57.03 Million
    Num Shares 10.6 Million
    EPS -4.84
    Price-to-Earnings (P/E) Ratio -1.11
    Price-to-Sales 0.00
    Price-to-Book 17.40
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.22
    Resistance 3 (R3) 6.25 6.00 6.08
    Resistance 2 (R2) 6.00 5.79 5.99 6.03
    Resistance 1 (R1) 5.70 5.66 5.85 5.67 5.99
    Pivot Point 5.45 5.45 5.53 5.44 5.45
    Support 1 (S1) 5.15 5.24 5.30 5.12 4.79
    Support 2 (S2) 4.90 5.11 4.89 4.75
    Support 3 (S3) 4.60 4.90 4.70
    Support 4 (S4) 4.57